Company / Current Assets
Nuo Therapeutics, Inc. Current Assets History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.2M
FY2017
5-year range
$1.2M / $21.4M
FY2013-FY2017
Trend
-64.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $1M in FY2017 to $21M in FY2014.
Based on SEC 10-K filings.
$1M in FY2017 with a 5-year CAGR of -28.7%.
Declined from $3M to $1M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -61.9%
- 5-Year CAGR
- -28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -28.7%, indicating a declining trend.
- In FY2017, current assets decreased 64.9% year-over-year.
- Peak current assets was recorded in FY2014.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $1.2M | -64.9% |
| FY2016 | $3.4M | +10.6% |
| FY2015 | $3.0M | -85.8% |
| FY2014 | $21.4M | +115.0% |
| FY2013 | $10.0M | +54.4% |
| FY2012 | $6.4M | +24.9% |
| FY2011 | $5.2M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026